The Luxembourg Institute of Health is seeking a post-doctoral researcher to make significant contributions to the project: “New tools for the prediction of influential nodes and links in multi-level cancer-related networks”, a Luxembourg-Singapore research partnership. [More]

Originally posted on 2017-03-07

Luxembourg is a dynamic multicultural country in the heart of Europe with a strong research and development culture supported by important financial and organisational resources. It offers state-of-the-art facilities and an excellent training environment for early-stage researchers, in particular in life sciences. CANBIO is a competitive PhD training program supported by the research funding scheme PRIDE of the Luxembourg National Research Fund (FNR). The CANBIO doctoral training unit will provide state-of-the-art structured PhD training in cancer biology and aims to bridge fundamental cancer research with clinically-oriented applications. The research-intensive program tackles next-generation cancer biology covering molecular mechanisms of tumour progression, treatment resistance and biomarker discovery, as well as building computational disease models to facilitate innovative translational research. It focuses on tumour escape mechanisms, thus addressing the increasingly important clinical problem of tumour recurrence and drug resistance. The program includes transferable skill training, support in career development, scientific lectures by international speakers and annual PhD retreats. PhD candidates will conduct their research project either at the Department of Oncology of the Luxembourg Institute of Health (LIH, Luxembourg), at the Life Sciences Research Unit of the University of Luxembourg (Campus Belval, Esch-sur-Alzette) or at the Laboratoire National de Santé (LNS, Dudelange). Several projects involve external collaborations and/or private companies providing insight into non-academic research environments. Depending on the project, PhD candidates will be enrolled at a doctoral school of the University of Luxembourg, the University of Bergen (Norway) or the University of Paris-Saclay (France). The program will allow the candidates to obtain a PhD degree in life sciences with a specialization in either: Tumour Microenvironment Tumour Metabolism Genomics of Cancer Biomarkers and Companion Diagnostics Bioinformatics and Systems Biology Drug Resistance Mechanisms View PhD project summaries here. Interested candidates can apply by clicking the “Apply Through Website” button. More specific information on CANBIO can be obtained from the program coordinator, Prof. Simone Niclou, Head of the NorLux Neuro-Oncology Laboratory at LIH’s Department of Oncology: canbio.office@lih.lu  [More]

Originally posted on 2016-07-21

Luxembourg Institute of Health: - Carry out his/her PhD project - Participate in the setting-up or execution of a research project and even in its finalization Project summary: GPCRs heterodimerization appears to play a role in modulating agonist/antagonist affinity, efficacy and Luxembourg  [More]

Originally posted on 2015-01-29